Stay updated on Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial

Sign up to get notified when there's something new on the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    21 days ago
    Change Detected
    Summary
    Added Revision: v3.3.2 and removed Revision: v3.2.0 in the Record History section. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:48:23.000Z thumbnail image
  3. Check
    28 days ago
    Change Detected
    Summary
    Removed a general government funding/operating-status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2025-11-17T17:44:29.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    The Record History page shows the same version list with dates; minor visual/layout changes are present. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T12:30:27.000Z thumbnail image
  5. Check
    71 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    13%
    Check dated 2025-10-05T17:29:06.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, signaling a new release/version without altering core content or critical data.
    Difference
    0.3%
    Check dated 2025-09-28T10:48:58.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2 instead of v3.0.1, and the Back to Top element was removed; overall content remains essentially the same.
    Difference
    0.8%
    Check dated 2025-09-14T00:38:25.000Z thumbnail image

Stay in the know with updates to Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page.